Search Results - "Wienkers, LC"
-
1
Factors confounding the successful extrapolation of in vitro CYP3A inhibition information to the in vivo condition
Published in European journal of pharmaceutical sciences (01-04-2002)“…For the most part, the majority of adverse drug–drug interactions, which are pharmacokinetic in origin, can be understood in terms of alterations of cytochrome…”
Get full text
Journal Article -
2
Predicting in vivo drug interactions from in vitro drug discovery data
Published in Nature reviews. Drug discovery (01-10-2005)“…In vitro screening for drugs that inhibit cytochrome P450 enzymes is well established as a means for predicting potential metabolism-mediated drug interactions…”
Get full text
Journal Article -
3
Pharmacology of AMG 181, a human anti‐α4β7 antibody that specifically alters trafficking of gut‐homing T cells
Published in British journal of pharmacology (01-05-2013)“…Background and Purpose AMG 181 is a human anti‐α4β7 antibody currently in phase 1 and 2 trials in subjects with inflammatory bowel diseases. AMG 181…”
Get full text
Journal Article -
4
Pyrene·Pyrene Complexes at the Active Site of Cytochrome P450 3A4: Evidence for a Multiple Substrate Binding Site
Published in Journal of the American Chemical Society (09-10-2002)“…Cytochrome P450 monooxygenases (CYPs) metabolize nearly all drugs and toxins. Recently, it has become clear that CYPs exhibit both homotropic and heterotropic…”
Get full text
Journal Article -
5
Pharmacology of AMG 181, a human anti-[alpha]4[beta]7 antibody that specifically alters trafficking of gut-homing T cells
Published in British journal of pharmacology (01-05-2013)“…Background and Purpose AMG 181 is a human anti-[alpha]4[beta]7 antibody currently in phase 1 and 2 trials in subjects with inflammatory bowel diseases. AMG 181…”
Get full text
Journal Article -
6
Pharmacology of AMG 181, a human anti‐α 4 β 7 antibody that specifically alters trafficking of gut‐homing T cells
Published in British journal of pharmacology (01-05-2013)“…Background and Purpose AMG 181 is a human anti‐α 4 β 7 antibody currently in phase 1 and 2 trials in subjects with inflammatory bowel diseases. AMG 181…”
Get full text
Journal Article -
7
Covalent Alteration of the CYP3A4 Active Site: Evidence for Multiple Substrate Binding Domains
Published in Archives of biochemistry and biophysics (01-07-2001)“…The inhibition of CYP3A4-mediated oxidation of triazolam and testosterone was assessed in the presence of a selection of known CYP3A4 substrates and…”
Get full text
Journal Article -
8
IN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMES
Published in Drug metabolism and disposition (01-07-2003)“…Incubations with human liver and gut microsomes revealed that the antibiotic, clindamycin, is primarily oxidized to form clindamycin sulfoxide. In this report,…”
Get full text
Journal Article -
9
Topological Alteration of the CYP3A4 Active Site by the Divalent Cation Mg2
Published in Drug metabolism and disposition (01-10-2000)“…Phenyldiazene reacted with lymphoblast-expressed CYP3A4 to give a stable phenyl-iron complex that could be induced to rearrange in situ producing approximately…”
Get full text
Journal Article -
10
Inhibition of Cytochrome P450 2D6: Structure−Activity Studies Using a Series of Quinidine and Quinine Analogues
Published in Chemical research in toxicology (01-04-2003)“…Several pharmacophore models have suggested that substrates and inhibitors of cytochrome P450 2D6 (P450 2D6) possess a nitrogen with a positive charge that…”
Get full text
Journal Article -
11
Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions
Published in Drug metabolism and disposition (01-10-1997)“…Human hepatic microsomes were used to investigate the carboxylesterase-mediated bioactivation of CPT-11 to the active metabolite, SN-38. SN-38 formation…”
Get full text
Journal Article -
12
Oxidation of the Novel Oxazolidinone Antibiotic Linezolid in Human Liver Microsomes
Published in Drug metabolism and disposition (01-09-2000)“…In vitro studies were conducted to identify the hepatic enzyme(s) responsible for the oxidative metabolism of linezolid. In human liver microsomes, linezolid…”
Get full text
Journal Article -
13
Triazolam Substrate Inhibition: Evidence of Competition for Heme-Bound Reactive Oxygen Within the CYP3A4 Active Site
Published in Drug metabolism and disposition (01-01-2001)“…In human liver microsomes, triazolam is principally metabolized by CYP3A4 to form two metabolites, 1â²-hydroxytriazolam (1â²OHTz) and 4-hydroxytriazolam…”
Get full text
Journal Article -
14
Effect of carbonate anion on cytochrome P450 2D6-mediated metabolism in vitro: the potential role of multiple oxygenating species
Published in Archives of biochemistry and biophysics (15-09-2003)“…Studies were designed to investigate various anions and their effects on cytochrome P450 2D6-mediated metabolism in vitro. Incubations were initially performed…”
Get full text
Journal Article -
15
Cytochrome P-450-Mediated Metabolism of the Individual Enantiomers of the Antidepressant Agent Reboxetine in Human Liver Microsomes
Published in Drug metabolism and disposition (01-11-1999)“…In vitro studies were conducted to identify the hepatic cytochrome P-450 (CYP) enzymes responsible for the oxidative metabolism of the individual enantiomers…”
Get full text
Journal Article -
16
Mechanism-Based Inactivation of Cytochrome P450 2D6 by 1-[(2-Ethyl-4-methyl-1H-imidazol-5-yl)methyl]- 4-[4-(trifluoromethyl)-2-pyridinyl]piperazine: Kinetic Characterization and Evidence for Apoprotein Adduction
Published in Chemical research in toxicology (01-02-2004)“…The kinetics for inactivation of cytochrome P450 2D6 by (1-[(2-ethyl-4-methyl-1H-imidazol-5-yl)methyl]-4-[4-(trifluoromethyl)-2-pyridinyl]piperazine (EMTPP)…”
Get full text
Journal Article -
17
Assessment of Potential Interactions Between Dopamine Receptor Agonists and Various Human Cytochrome P450 Enzymes Using a Simple In Vitro Inhibition Screen
Published in Drug metabolism and disposition (01-10-1997)“…The selectivity of inhibition for four dopamine receptor agonists (pramipexole, ropinirole, pergolide, and bromocriptine) on six human cytochrome P450 enzyme…”
Get full text
Journal Article -
18
Multiple Cytochrome P450 Enzymes Responsible for the Oxidative Metabolism of the Substituted (S)-3-Phenylpiperidine, (S,S)-3-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine Hydrochloride, in Human Liver Microsomes
Published in Drug metabolism and disposition (01-12-2002)“…( S , S )-3-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine hydrochloride [(â)-OSU6162] is a weak dopamine D2 receptor modulator that possesses potential for…”
Get full text
Journal Article -
19
Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19
Published in Drug metabolism and disposition (01-05-1996)“…Kinetic studies demonstrate that two forms of human liver cytochrome P450 are responsible for the formation of (R)-8-hydroxywarfarin: a low-affinity enzyme (KM…”
Get more information
Journal Article -
20
Problems associated with in vitro assessment of drug inhibition of CYP3A4 and other P-450 enzymes and its impact on drug discovery
Published in Journal of pharmacological and toxicological methods (2001)“…The cytochromes P-450 recognize and metabolize a broad range of structurally diverse therapeutic agents. As a consequence, many clinically relevant drug–drug…”
Get full text
Journal Article